glp-1 therapy houma Compounded GLP-1 injection Novo Nordisk Drops Hims &

(This is based on when you started the medication not your current weight) BMI of 35 or higher when you started, OR BMI of 30 or higher AND a serious heart or kidney condition, OR BMI of 27 or higher AND a history of heart attack, stroke, or pre-diabetes 3

These side effects are usually less common at lower doses and may be noticeable at higher doses

Compounded medications are not FDA-approved but are prepared in FDA-registered and inspected compounding pharmacies to meet specific patient needs

Recent advances in radiochemistry have enhanced the clinical feasibility of these platforms

Key genetic markers like GLP1R rs6923761 and FTO rs9939609 influence both baseline hunger drive and medication effectiveness

Seek medical advice if you are unable to keep fluids down or notice a significant reduction in urine output